Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-damaged Skin
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study is primarily designed to evaluate the safety and tolerability of PEP005 Gel,
0.015% when administered for up to three consecutive days to photo-damaged skin on the face.
The secondary endpoint is to determine the efficacy of PEP005 Gel, 0.015% when administered
for up to three consecutive days in patients with photo-damaged skin on the face.